- Home
- VICI vs ONC Comparison
VICI vs ONC Comparison
Compare VICI & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VICI
- ONC
- Stock Information
- Founded
- VICI 2016
- ONC 2010
- Country
- VICI United States
- ONC Switzerland
- Employees
- VICI N/A
- ONC N/A
- Industry
- VICI Real Estate Investment Trusts
- ONC Biotechnology: Pharmaceutical Preparations
- Sector
- VICI Real Estate
- ONC Health Care
- Exchange
- VICI Nasdaq
- ONC Nasdaq
- Market Cap
- VICI 35.4B
- ONC 34.8B
- IPO Year
- VICI N/A
- ONC N/A
- Fundamental
- Price
- VICI $29.70
- ONC $314.85
- Analyst Decision
- VICI Buy
- ONC Strong Buy
- Analyst Count
- VICI 13
- ONC 10
- Target Price
- VICI $36.23
- ONC $350.00
- AVG Volume (30 Days)
- VICI 8.5M
- ONC 216.9K
- Earning Date
- VICI 10-30-2025
- ONC 11-06-2025
- Dividend Yield
- VICI 6.06%
- ONC N/A
- EPS Growth
- VICI 2.38
- ONC N/A
- EPS
- VICI 2.61
- ONC N/A
- Revenue
- VICI $3,926,259,000.00
- ONC $4,562,002,000.00
- Revenue This Year
- VICI $5.50
- ONC $887.89
- Revenue Next Year
- VICI $2.68
- ONC $22.45
- P/E Ratio
- VICI $11.38
- ONC N/A
- Revenue Growth
- VICI 4.85
- ONC 47.33
- 52 Week Low
- VICI $27.98
- ONC $170.99
- 52 Week High
- VICI $34.03
- ONC $355.30
- Technical
- Relative Strength Index (RSI)
- VICI 26.23
- ONC 45.02
- Support Level
- VICI $31.14
- ONC $306.00
- Resistance Level
- VICI $31.69
- ONC $320.35
- Average True Range (ATR)
- VICI 0.45
- ONC 8.04
- MACD
- VICI -0.08
- ONC -1.36
- Stochastic Oscillator
- VICI 8.92
- ONC 33.54
About VICI VICI Properties Inc.
VICI Properties Inc is a real estate investment trust based in the United States. It engaged in the business of owning and acquiring gaming, hospitality, wellness, entertainment and leisure destinations, subject to long-term triple net leases. It own nearly 93 experiential assets across a geographically portfolio consisting of nearly 54 gaming properties and nearly 39 other experiential properties across the United States and Canada, including Caesars Palace Las Vegas, MGM Grand and the Venetian Resort Las Vegas.
About ONC BeiGene Ltd. American Depositary Shares
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.